Instructions for Authors

https://www.scholarscentral.org/submissions/research-reviews-hospital-clinical-pharmacy.html or send as an e-mail attachment to the Editorial Office at manuscript@rroij.com

Journal Impact Factor : 0.87

Research & Reviews: Journal of Hospital and Clinical Pharmacyis self-financed and does not receive funding from any institution/government. Hence, the Journal operates solely through processing charges we receive from the authors and some academic/corporate sponsors. The handling fee is required to meet its maintenance. Being an Open Access Journal, Journal of Hospital and Clinical Pharmacy does not collect subscription charges from readers that enjoy free online access to the articles. Authors are hence required to pay a fair handling fee for processing their articles. However, there are no submission charges. Authors are required to make payment only after their manuscript has been accepted for publication.

The basic article processing fee or manuscript handling cost is as per the price mentioned above on the other hand it may vary based on the extensive editing, colored effects, complex equations, extra elongation of no. of pages of the article, etc.

Fast Editorial Execution and Review Process (FEE-Review Process):

Research & Reviews: Journal of Hospital and Clinical Pharmacy is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.

Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.

The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.

• Authors are expected to attach an electronic covering letter completely mentioning the type of manuscript (e.g, Research article, Review articles, Brief Reports, Case study etc.) Unless invited on a special case, authors cannot classify a particular manuscript as Editorials or Letters to the editor or concise communications.
• Confirm that each individual named as an author meets the uniform requirements of the Journal of Hospital and Clinical Pharmacy criteria for authorship.
• Please make sure that the article submitted for review/publication is not under consideration elsewhere simultaneously.
• Clearly mention financial support or benefits if any from commercial sources for the work reported in the manuscript, or any other financial interests that any of the authors may have, which could create a potential conflict of interest or the appearance of a conflict of interest with regard to the work.
• A clear title of the article along with complete details of the author/s (professional/institutional affiliation, educational qualifications and contact information) must be provided in the tile page.
• Corresponding author should include address, telephone number, fax number, and e-mail address in the first page of the manuscript and authors must address any conflict of interest with others once the article is published.
• Number all sheets in succession, including references, tables, and figure legends.
• Title page is page 1. On the first page, type the running head (short title for top of each page), title (which cannot include any acronyms), names of the authors and their academic degrees, grants or other financial supporters of the study, address for correspondence and reprint requests, and corresponding author's telephone and fax numbers and e-mail address.

• Research articles are articles written based on the empirical/secondary data collected using a clearly defined research methodology, where conclusion/s is drawn from the analysis of the data collected.
• The information must be based on original research that adds to the body of knowledge in Journal of Hospital and Clinical Pharmacy.
• Article/s should provide a critical description or analysis of the data presented while adding new and rapidly evolving areas in the field.
• Include an abstract of maximum 300 words with 7 to 10 important keywords.
• The abstract should be divided into Objective, Methods, Results, and Conclusion.
• Research articles must adhere to a format constituting the introduction followed by a brief review of relevant literature, methodology applied (to collect the data), discussion and References, Tables, and Figure Legends.

• Review articles are written based mostly on secondary data that is falling in line with the theme of the journal. They are brief, yet critical discussions on a specific aspect of the subject concerned. Reviews generally start with the statement of the problem with a brief abstract of 300 words and few key words. Introduction generally brings the issue forward to the readers followed by analytical discussion with the help of necessary tables, graphs, pictures and illustrations wherever necessary. It summarizes the topic with a conclusion. All the statements or observations in the review articles must be based on necessary citations, providing complete reference at the end of the article.

• Commentaries are opinion articles written mostly by the veteran and experienced writers on a specific development, recent innovation or research findings that fall in line with the theme of the journal. They are very brief articles with the title and abstract that provides the gist of the topic to be discussed, with few key words. It straight away states the problems and provides a thorough analysis with the help of the illustrations, graphs and tables if necessary. It summarizes the topic with a brief conclusion, citing the references at the end.

• Case studies are accepted with a view to add additional information related to the investigative research that advances in the field of Cliniacl Pharmacy.
• It should add value to the main content/article submitted, by providing key insights about the core area. Cases reports must be brief and follow a clear format such as Cases and Methods Section (That describe the nature of the clinical issue and the methodology adopt to address it), discussion section that analyzes the case and a Conclusion section that sums up the entire case.

• Editorials are concise commentaries on a currently published article/issue on Clinical Pharmacy. Editorial office may approach for any such works and authors must submit it within three weeks from the date of receiving invitation.

•  Letters to the editor should be limited to commentaries on previous articles published with specific reference to issues and causes related to it. It should be concise, comprehensive and brief reports of cases or research findings. It does not follow a format such as abstract, subheads, or acknowledgments. It is more a response or the opinion of the reader on a particular article published and should reach the editor within 6 months of article publication.

1. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
2. Brusic V, Rudy G, Honeyman G, Hammer J, Harrison L (1998) Prediction of MHC class II- binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics 14: 121-130.
3. Doroshenko V, Airich L, Vitushkina M, Kolokolova A, Livshits V, et al. (2007) YddG from Escherichia coli promotes export of aromatic amino acids. FEMS Microbiol Lett 275: 312-318.

http://www.ncbi.nlm.nih.gov/books/NBK25500/

1. Baggot JD (1999) Principles of drug disposition in domestic animals: The basis of Veterinary Clinical Pharmacology. (1stedn), W.B. Saunders Company, Philadelphia, London, Toranto.
2. Zhang Z (2006) Bioinformatics tools for differential analysis of proteomic expression profiling data from clinical samples. Taylor & Francis CRC Press.

1. Hofmann T (1999) The Cluster-Abstraction Model: unsupervised learning of topic hierarchies from text data. Proceedings of the International Joint Conference on Artificial Intelligence.